Phase Ib study of WNT inhibitor ipafricept (IPA) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (mPC).-MedSci.cn

Phase Ib study of WNT inhibitor ipafricept (IPA) with nab-paclitaxel (Nab-P) and gemcitabine (G) in patients (pts) with previously untreated stage IV pancreatic cancer (mPC).

Dotan, E; Cardin, DB; Lenz, HJ; Messersmith, WA; O'Neil, B; Cohen, SJ; Denlinger, CS; Shahda, S; Kapoun, AM; Brachmann, RK; Uttamsingh, S; Weekes, CD

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (4):

科室
- - 订阅+
  - 更多科室
工具
服务